ASH2L and breast carcinoma: RNA-seq and ChIP-qPCR were performed to elucidate the underlying mechanism.<h4>Results</h4>High ASH2L amplification correlated with poor prognosis in tamoxifen-treated ER-positive breast cancer patients.